An O-Antigen Glycoconjugate Vaccine Produced Using Protein Glycan Coupling Technology Is Protective in an Inhalational Rat Model of Tularemia
Journal of Immunology Research - Egypt
doi 10.1155/2018/8087916
Full Text
Open PDFAbstract
Available in full text
Date
November 29, 2018
Authors
Publisher
Hindawi Limited